Pfizer Says Vaccine Is 95% Effective

After concluding a phase 3 study of its COVID-19 vaccine candidate, Pfizer revealed Wednesday that the vaccine has 95% efficiency.

Here & Now's Robin Young gets the latest from Helen Branswell, senior writer at STAT, the health and medicine publication.